Breast Density and Breast Cancer Screening with Digital Breast Tomosynthesis: A TOSYMA Trial Subanalysis
Radiology. 2023 Feb;306(2):e221006. doi: 10.1148/radiol.221006. Epub 2022 Oct 4.
Lessons Learned from the Randomized Controlled TOmosynthesis plus SYnthesized MAmmography (TOSYMA) Trial
Radiology. 2022 Oct 4:221006. doi: 10.1148/radiol.222178
Erste Ergebnisse zur multizentrischen, randomisierten, kontrollierten Brustkrebs-Diagnostikstudie ToSyMa
Senologie - Zeitschrift für Mammadiagnostik und -therapie 2022; 18(02): 125-126 DOI: 10.1055/a-1826-6228
Digital breast tomosynthesis plus synthesized mammography versus digital screening mammography for the detection of invasive breast cancer (TOSYMA): a multicentre, open-label, randomized, controlled, superiority trial
Lancet Oncol. 2022 May;23(5):601-611. doi: 10.1016/S1470-2045(22)00194-2. Epub 2022 Apr 12.
Das Mammografie-Screening: Sollte es abgeschafft werden?
Geburtshilfe Frauenheilkd 2021; 81(09): 1011-1013 DOI: 10.1055/a-1372-7531
Simultaneous FAPI PET/MRI Targeting the Fibroblast-Activation Protein for Breast Cancer
Radiology 2021; 000:1–9 https://doi.org/10.1148/radiol.2021204677